A Phase I, Randomised, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1386 in Healthy Caucasian Young and Elderly Subjects After Oral Multiple Doses.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2010
At a glance
- Drugs AZD 1386 (Primary)
- Indications Pain
- Focus Adverse reactions
- 09 Dec 2010 Last checked against ClinicalTrials.gov record.
- 23 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jun 2008 New trial record.